Genmab AS (GMAB) earnings
In the quarter ended June 2024, Genmab AS had revenue of 5.4B DKK, down 0.9% on a year earlier, and diluted EPS of 21.70.
On August 6, 2026 it reported EPS of 0.54 against an estimate of 0.37 (beat).
The next report is expected on Thursday, November 5, 2026 before the market opens, with EPS expected around 0.37.
Report dates
| Report | Date | Time | EPS estimate | EPS reported |
|---|---|---|---|---|
| Next | Thu Nov 5, 2026 | Before open | 0.37 | — |
| Last | Thu Aug 6, 2026 | After close | 0.37 | 0.54 |
Dates from company announcements and exchange calendars; estimates are the consensus where available. See the full earnings calendar.
Quarterly results
The last 7 quarters from Genmab AS's 10-Q and 10-K filings with the SEC, in DKK. Growth is against the same quarter a year earlier. EPS here is GAAP diluted EPS as filed; the reported EPS compared with estimates above can be on the company's adjusted basis, so the two can differ.
| Quarter ended | Revenue | Growth | EPS (diluted) | Growth | Op. margin | Filed |
|---|---|---|---|---|---|---|
| Jun 30, 2024 | 5.4B DKK | -0.9% | 21.70 | -57.7% | 30.4% | 2024-08-08 |
| Jun 30, 2023 | 4.2B DKK | +438.6% | 20.28 | +1402.2% | 35.2% | 2023-08-03 |
| Jun 30, 2022 | 3.2B DKK | +520.4% | 28.66 | +580.8% | 39.4% | 2022-08-10 |
| Jun 30, 2021 | 2.0B DKK | — | 4.64 | — | 39.9% | 2021-08-11 |
| Jun 30, 2020 | 5.5B DKK | — | 51.35 | — | 82.5% | 2020-08-12 |
| Jun 30, 2019 | 774M DKK | — | 1.35 | — | 17.7% | 2019-08-14 |
| Jun 30, 2018 | 510M DKK | — | 4.21 | — | 26.5% | 2019-08-14 |
Questions
When does Genmab AS report earnings?
Genmab AS's next earnings report is expected on November 5, 2026 before the market opens.
How did Genmab AS do last quarter?
In the quarter ended June 2024, Genmab AS had revenue of 5.4B DKK, down 0.9% on a year earlier, and diluted EPS of 21.70.
From Genmab AS's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.